Bio Protocol has launched an upgraded protocol Bio V1, introducing a Launchpad, where BIO holders can gain priority access to early project allocations.

BlockBeats news, on April 1, the decentralized protocol Bio Protocol, aimed at early-stage biotechnology, announced the launch of its first major protocol upgrade – Bio V1 on Solana and Base. V1 introduces several features designed to simplify and optimize early-stage biotechnology financing and development, and to increase novel incentive mechanisms, including: · A community-governed Launchpad for early financing; · A liquidity and incentive engine that supports instant liquidity post-financing and rewards linked to scientific milestones; · BioAgents, AI-driven agents capable of automating research tasks such as R&D data analysis and experimental design. BIO token holders can decide which biotechnology projects get launched and their direction of development. In return, they gain priority access to early allocations of successful projects on the network. During the selection process, BIO token holders determine which new BioDAOs can receive funding on the Bio V1 launchpad. Investing in BIO will grant discounts on BioDAO tokens.